SCHEMBL31712895

SCHEMBL31712895

NC(=O)c1ccc2ncc3ncncc3c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 2/20 0.43
CSNK2B P67870 2/20 0.43
CD38 P28907 1/20 0.40
PDE5A O76074 1/20 0.40
AR P10275 1/20 0.40
CSNK2A1 P68400 1/20 0.39
MAP4K4 O95819 1/20 0.39
IP6K1 Q92551 1/20 0.38
NNMT P40261 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
PKN1 Q16512 1/20 0.36
PKN2 Q16513 1/20 0.36
APP P05067 1/20 0.36
EGFR P00533 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29800333 0.88 CSNK2A2 (0.51) CSNK2A2CSNK2BARCSNK2A1NNMT
SCHEMBL31712846 0.80 LCK (0.40) CSNK2A2CSNK2BEGFR
SCHEMBL31712837 0.78 MAPK10 (0.48) CSNK2A2CSNK2BARCSNK2A1MAP4K4
SCHEMBL29649950 0.78 EGFR (0.56) CSNK2A2CSNK2BARNNMTSMN1; SMN2
SCHEMBL5676295 0.78 EGFR (0.56) CSNK2A2CSNK2BARNNMTSMN1; SMN2
SCHEMBL27881435 0.76 EGFR (0.54) CSNK2A2CSNK2BARNNMTSMN1; SMN2
SCHEMBL30504719 0.75 CSNK2A2 (0.46) CSNK2A2CSNK2BARCSNK2A1PKN1
SCHEMBL8003414 0.74 PDE5A (0.45) CD38PDE5AMAP4K4IP6K1NNMT
SCHEMBL2051696 0.74 EGFR (0.56) CSNK2A2CSNK2BARCSNK2A1NNMT
SCHEMBL15534806 0.72 MAP2K7 (0.50) CSNK2A2CSNK2BARCSNK2A1NNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251624-B1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC (US) 2025-10-29 EP claimed